About ClearPath Diagnostics
ClearPath Diagnostics is a company based in Syracuse (United States) founded in 1975 was acquired by LabCorp in October 2016. ClearPath Diagnostics operates in a competitive market with competitors including Surge, Aurora Diagnostics, Bioreference, Sonic Healthcare USA and AmeriPath, among others.
- Headquarter Syracuse, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ClearPath Diagnostics
Investors in ClearPath Diagnostics
ClearPath Diagnostics has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include LabCorp, Shore Capital Partners and Tenth Street Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Shore Capital Partners is engaged in private equity investments for small to mid-sized businesses.
|
Locked | Locked | Locked | |
|
Tenth Street Advisors is engaged in providing capital to lower middle market companies.
|
Locked | Locked | Locked | |
|
Provider of laboratory tests for physicians
|
Locked | Locked | Locked |
Investor details for ClearPath Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClearPath Diagnostics
Investment portfolio details for ClearPath Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ClearPath Diagnostics
Detailed financials for ClearPath Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clearpath Diagnostics Comparisons
Peer comparison for ClearPath Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ClearPath Diagnostics
ClearPath Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Surge, Aurora Diagnostics, Bioreference, Sonic Healthcare USA and AmeriPath, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surge is focused on Bitcoin finance solutions and innovations.
|
|
| Locked | Locked | Locked |
Pathology laboratory services are provided through a chain of facilities.
|
|
| Locked | Locked | Locked |
Pathology laboratory services are operated through a nationwide chain.
|
|
| Locked | Locked | Locked |
Offers diagnostic testing and laboratory services to healthcare providers and hospitals.
|
|
| Locked | Locked | Locked |
Chain of pathology laboratories
|
|
| Locked | Locked | Locked |
Pathology diagnostic services are delivered via a chain of labs.
|
Detailed competitors of ClearPath Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clearpath Diagnostics
Complete news archive for ClearPath Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClearPath Diagnostics
ClearPath Diagnostics was founded in 1975 and raised its 1st funding round 36 years after it was founded.
ClearPath Diagnostics is headquartered in Syracuse, United States. It is registered at Syracuse, New York, United States.
Jack Finn is the current CEO of ClearPath Diagnostics.
ClearPath Diagnostics was founded in 1975 and operates as a chain of pathology laboratories in the United States, with its headquarters located in Syracuse. Diagnostic testing services are provided across various medical fields, including clinical pathology and laboratory analysis. Operations focus on accurate sample processing and result delivery for healthcare providers and patients throughout the region. The company is led by CEO Jack Finn.
ClearPath Diagnostics's top competitors include Bioreference, Aurora Diagnostics and AmeriPath.
ClearPath Diagnostics has 3 investors. Key investors include LabCorp, Shore Capital Partners, and Tenth Street Advisors.